Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% hypertonic saline duration in infant bronchiolitis
NCT02538458Phase 4Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Nov 2014
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
A Phase 4 trial of hypertonic saline in bronchiolitis, sponsored by CHU Grenoble Alpes. Started Nov 2014; status: completed.
02
Drugs
hypertonic saline
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT02538458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538458.